Combined Regimen Shows Recurrent Glioblastoma Potential

Glioblastoma trial results support further investigation of a bevacizumab–lomustine regimen...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.